榮科科技(300290.SZ):擬向建設銀行申請1億元授信額度
格隆匯10月15日丨榮科科技(300290.SZ)公佈,公司於2021年10月14日召開第四屆董事會第三十八次會議審議通過了《關於向建設銀行申請授信額度的議案》,此次擬向建設銀行鐵西支行申請授信額度1億元,其中:敞口授信額度8500萬元,期限為1年。
此次授信由公司、北京榮科愛信科技有限公司及遼寧榮科金融服務有限公司提供房產及土地使用權抵押,公司及北京神州視翰科技有限公司以其截至2020年12月31日所擁有的部分專利及全部著作權質押,公司法人何任暉及其配偶為此次授信提供連帶責任擔保,同時公司控股股東遼寧國科實業有限公司為此次授信提供連帶責任保證擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.